Synthetic polypeptides: from polymer design to supramolecular assembly and biomedical application

Z Song, Z Han, S Lv, C Chen, L Chen, L Yin… - Chemical Society …, 2017 - pubs.rsc.org
Synthetic polypeptides from the ring-opening polymerization of N-carboxyanhydrides
(NCAs) are one of the most important biomaterials. The unique features of these synthetic …

Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery

H Wang, L Qin, X Zhang, J Guan, S Mao - Journal of Controlled Release, 2022 - Elsevier
With the rapid development of biopharmaceuticals and the outbreak of COVID-19, the world
has ushered in a frenzy to develop gene therapy. Therefore, therapeutic genes have …

Co-encapsulation of Cas9 mRNA and guide RNA in polyplex micelles enables genome editing in mouse brain

S Abbasi, S Uchida, K Toh, TA Tockary… - Journal of Controlled …, 2021 - Elsevier
Genome editing using CRISPR/Cas9 has attracted considerable attention for the treatment
of genetic disorders and viral infections. Co-delivery of Cas9 mRNA and single guide (sg) …

Polymer gene delivery: overcoming the obstacles

A Aied, U Greiser, A Pandit, W Wang - Drug discovery today, 2013 - Elsevier
Highlights•Minor modifications to polymer structure determine transfection
properties.•Efficient gene delivery requires timely release of DNA.•Serum stability is …

Polyplex designs for improving the stability and safety of RNA therapeutics

S Uchida, CYJ Lau, M Oba, K Miyata - Advanced Drug Delivery Reviews, 2023 - Elsevier
Nanoparticle-based delivery systems have contributed to the recent clinical success of RNA
therapeutics, including siRNA and mRNA. RNA delivery using polymers has several distinct …

Systemic delivery of messenger RNA for the treatment of pancreatic cancer using polyplex nanomicelles with a cholesterol moiety

S Uchida, H Kinoh, T Ishii, A Matsui, TA Tockary… - Biomaterials, 2016 - Elsevier
Systemic delivery of messenger RNA (mRNA) is technically challenging because mRNA is
highly susceptible to enzymatic degradation in the blood circulation. In this study, we used a …

Differential bioreactivity of neutral, cationic and anionic polystyrene nanoparticles with cells from the human alveolar compartment: robust response of alveolar type 1 …

P Ruenraroengsak, TD Tetley - Particle and fibre toxicology, 2015 - Springer
Background Engineered nanoparticles (NP) are being developed for inhaled drug delivery.
This route is non-invasive and the major target; alveolar epithelium provides a large surface …

Design concepts of polyplex micelles for in vivo therapeutic delivery of plasmid DNA and messenger RNA

S Uchida, K Kataoka - … of Biomedical Materials Research Part A, 2019 - Wiley Online Library
Nonviral delivery of plasmid (p) DNA or messenger (m) RNA is a safe and promising
therapeutic option to continuously supply therapeutic proteins into diseased tissues. In most …

Pulmonary siRNA delivery for lung disease: review of recent progress and challenges

L Ding, S Tang, TA Wyatt, DL Knoell… - Journal of controlled …, 2021 - Elsevier
Lung diseases are a leading cause of mortality worldwide and there exists urgent need for
new therapies. Approval of the first siRNA treatments in humans has opened the door for …

Polycations and their biomedical applications

K Kim, WCW Chen, Y Heo, Y Wang - Progress in Polymer Science, 2016 - Elsevier
Polycations are useful delivery vehicles for nucleic acids and proteins. Physicochemical
properties, safety, and cost are important design parameters for polycation-enabled …